1. Introduction {#sec1-ijerph-17-05556}
===============

Approximately one billion adults worldwide experience non-specific spinal pain \[[@B1-ijerph-17-05556]\]. The term "non-specific pain" is used because this type of pain cannot be reliably attributed to a specific underlying condition, such as cancer, infection, or inflammatory disease \[[@B2-ijerph-17-05556]\]. Due to this absence of underlying disease, healthcare professionals find the clinical assessment and treatment of such patients extremely difficult \[[@B3-ijerph-17-05556]\]. The use of healthcare services and medication intake is not only higher in patients with chronic pain than in the general population, but is even higher in those with spinal pain \[[@B4-ijerph-17-05556]\]. Thus, health service funders and patients experience increased costs \[[@B5-ijerph-17-05556]\]. Apart from the economic aspects, there is a risk of over-treatment. Furthermore, patients often experience high levels of emotional frustration because of the apparently endless succession of fruitless tests, consultations, and changes in medication. These feelings of frustration are often associated with both anger and a sense of perceived injustice, which are typically directed toward health professionals \[[@B6-ijerph-17-05556],[@B7-ijerph-17-05556],[@B8-ijerph-17-05556]\]. Thus, the rehabilitation process is hindered \[[@B9-ijerph-17-05556],[@B10-ijerph-17-05556]\].

A recent review showed that very few studies have analyzed the association between the increased use of healthcare services and chronic pain, despite the recognized importance of this topic \[[@B11-ijerph-17-05556]\]. Associations have been found between the increased use of healthcare services and factors, such as pain-related disability \[[@B12-ijerph-17-05556]\], pain intensity \[[@B13-ijerph-17-05556]\], age \[[@B14-ijerph-17-05556]\], depression \[[@B15-ijerph-17-05556]\], and sex \[[@B16-ijerph-17-05556]\]. A Spanish study found that the healthcare system was mainly used by individuals who leave or lose their job as a result of pain \[[@B17-ijerph-17-05556]\]. Associations have been found between some psychological factors related with pain chronification (e.g., fear-avoidance beliefs and pain catastrophizing) and healthcare service use \[[@B18-ijerph-17-05556],[@B19-ijerph-17-05556]\].

Evidence has also been found of associations between higher pain acceptance and fewer medical visits and less drug consumption \[[@B20-ijerph-17-05556],[@B21-ijerph-17-05556],[@B22-ijerph-17-05556],[@B23-ijerph-17-05556]\]. Acceptance is a key process within the Psychological Flexibility Model \[[@B24-ijerph-17-05556]\]. Pain acceptance entails responding to pain-related experiences without attempts at control or avoidance \[[@B20-ijerph-17-05556]\]. This aspect is of particular relevance when such attempts limit the patients' quality of life and stop them from engaging in valued activities and reaching personal goals \[[@B25-ijerph-17-05556]\]. From this theoretical perspective, high medication consumption and treatment seeking, in contrast to an acceptance response, have been conceptualized as forms of avoidance behavior \[[@B25-ijerph-17-05556]\]. Several prospective cohort studies have found an association between pain acceptance and better general functioning and work status, and less disability, emotional distress, and healthcare utilization in groups of patients with chronic pain, regardless of their pain intensity \[[@B20-ijerph-17-05556],[@B21-ijerph-17-05556],[@B22-ijerph-17-05556]\].

Thus, it is relevant to (a) study the predictive power of pain acceptance in relation to healthcare utilization and medication intake, and (b) investigate the status of this construct as a meaningful addition to other predictive factors that have been the object of previous studies. Cross-sectional studies are the main source of results regarding these factors, and thus, longitudinal research is needed to determine their predictive power. The study objective was to prospectively assess the predictive value of pain acceptance and the aforementioned factors in relation to healthcare utilization and medication intake in patients with non-specific spinal pain. The following hypotheses were formulated: **Hypothesis 1** **(H1).**Increased healthcare service use and medication intake would be prospectively predicted by pain-related disability, pain intensity, depression, age, sex, work status, pain anxiety, and pain catastrophizing. **Hypothesis 2** **(H2).**Reduced healthcare service use and medication intake would be prospectively predicted by pain acceptance.

To the best of our knowledge, this is the first prospective study to investigate the predictive value of pain acceptance and a wide range of other factors that have been investigated in other studies. In contrast to such studies \[[@B20-ijerph-17-05556],[@B21-ijerph-17-05556],[@B22-ijerph-17-05556]\], all the participants recruited in the present study were (a) in the early phase of chronic non-specific spinal pain, (b) had been experiencing pain for a similar period (i.e., 6--9 months), and (c) were followed up over a long period (1 year), which included two measurement occasions.

2. Materials and Methods {#sec2-ijerph-17-05556}
========================

2.1. Procedure {#sec2dot1-ijerph-17-05556}
--------------

This study was part of a larger research project \[[@B26-ijerph-17-05556]\]. The project was conducted in accordance with the Declaration of Helsinki and received ethical clearance by the Institutional Ethics Review Board (ERC UMA) and the Regional Hospital Ethics Committee. At the end of visits to their doctors, the patients who met the eligibility criteria were informed of the study aims, and their participation was requested. Some participants were interviewed after their visit, whereas others left their telephone number to make an appointment on another day. Written informed consent was obtained prior to data collection. Each participant had a semi-structured interview with a psychologist and also completed a battery of questionnaires. The approximate duration of the session was 45 minutes. Baseline demographic and clinical variables were assessed, as well as the predictive variables. Healthcare utilization and medication intake related to the primary pain complaint were assessed at follow-ups 1 and 2. Five primary care units participated in the study, which were located in different urban and rural areas. The participants were always interviewed in their usual primary care center.

2.2. Participants {#sec2dot2-ijerph-17-05556}
-----------------

General practitioners in five primary care units recruited 86 patients whose primary complaint was non-specific spinal pain. Individuals were considered eligible for inclusion if they met the following criteria: (a) being between 18 and 65 years of age; (b) able to understand written and spoken Spanish; (c) had non-specific spinal pain in the cervical, thoracic, or lumbosacral regions; (d) spinal pain of 6 to 9 months' duration; and (e) pain intensity equal to or higher than 3 on a 10-point scale.

The exclusion criteria were: (a) being treated for malignant tumors, terminal illness, or psychiatric disorder; (b) spinal pain that was related to or secondary to a specific medical condition (tumors, trauma, infection, fractures, and inflammatory disorders); (c) chronic widespread syndromes (e.g., fibromyalgia, chronic fatigue syndrome); (d) surgery in the spinal area; and (e) pregnancy. Seven of the participants (9%) were excluded because they did not meet the inclusion criteria, or they met one of the exclusion criteria.

In total, 79 patients participated in the study (64 women and 15 men). All participants were Caucasian, and their average age was 50.89 years (SD = 14.11). The marital status of the participants was as follows: married (59.50%), never married (27.80%), cohabiting (3.8%), widowed (5.1%), and separated (3.8%). In total, 38% had completed primary school, 34.2% had completed high school, and 16.5% had a university degree. Pain sites were as follows: cervical (59.5%), vertebral-lumbar (32.9%), sacral (30.4%), thoracic (30.4%), and lumbar-renal (21.5%).

The participants were assessed on three occasions (see [Figure 1](#ijerph-17-05556-f001){ref-type="fig"} for the study flowchart). The baseline assessment was conducted at 6 to 9 months of pain duration and two more assessments were made at 6-month intervals. The two follow-ups (i.e., follow-ups 1 and 2) were specifically scheduled independently from the participants' standard medical checkups. Sixty-three participants completed follow-up 1, and 59 participants completed follow-up 2. The participants who completed the three assessment sessions (*N* = 59) were compared to those who did not complete them. No significant differences were found between the groups in relation to any of the study variables.

2.3. Variables and Instruments {#sec2dot3-ijerph-17-05556}
------------------------------

### 2.3.1. Demographic and Clinical Pain-Related Variables {#sec2dot3dot1-ijerph-17-05556}

A semi-structured interview was used to collect data on demographic and pain-related variables including age, sex, civil status, education, work status, pain duration, pain location, medications being taken, and healthcare use.

### 2.3.2. Pain intensity {#sec2dot3dot2-ijerph-17-05556}

Participants were asked to rate their least, average, and worst pain during the previous two weeks, as well as their current pain, on a scale ranging from 0 to 10. A rating of 0 indicated "no pain", and 10 indicated pain "as intense as you could imagine". A composite pain intensity score was calculated for each participant by calculating the average of the least, average, worst, and current pain, with higher scores indicating higher perceived pain intensity. Composites of the 0--10 ratings are very reliable measures of pain intensity in patients with chronic pain \[[@B27-ijerph-17-05556]\].

### 2.3.3. Anxiety and Depression Scale {#sec2dot3dot3-ijerph-17-05556}

Depression was assessed using the Depression subscale of the Spanish version of the Hospital Anxiety and Depression Scale, which is a self-reporting scale comprising seven items (item score 1--4) \[[@B28-ijerph-17-05556],[@B29-ijerph-17-05556]\]. The total score ranges from 0 to 28, with higher scores indicating higher depression. The internal consistency of the subscale is high (α = 0.86) \[[@B28-ijerph-17-05556]\].

### 2.3.4. Pain Catastrophizing {#sec2dot3dot4-ijerph-17-05556}

Pain-related catastrophizing was assessed using the Spanish adaptation of the Pain Catastrophizing Scale \[[@B30-ijerph-17-05556],[@B31-ijerph-17-05556]\]. It consists of three subscales assessing rumination, magnification and helplessness and also provides a total score on catastrophizing. The total score alone was used in this study. Items are scored on a five-point ordinal scale. The total score ranges from 0 to 52 points, with higher scores corresponding to higher levels of pain catastrophizing. The Spanish version of the scale shows appropriate reliability and validity. Internal consistency was high (α = 0.79) \[[@B30-ijerph-17-05556]\].

### 2.3.5. Pain Anxiety {#sec2dot3dot5-ijerph-17-05556}

Anxiety and fear responses associated with chronic pain were measured using the Spanish adaptation of the Pain Anxiety Symptoms Scale \[[@B32-ijerph-17-05556],[@B33-ijerph-17-05556]\]. This scale comprises 20 items scored on a six-point scale. The total score ranges from 0 to 100 points, with higher scores indicating higher levels of pain anxiety. The Spanish version of the questionnaire showed high internal consistency (α = 0.93) \[[@B32-ijerph-17-05556]\].

### 2.3.6. Pain Acceptance {#sec2dot3dot6-ijerph-17-05556}

Pain acceptance was measured using the Spanish version of the Pain Acceptance Questionnaire \[[@B34-ijerph-17-05556],[@B35-ijerph-17-05556]\]. This instrument comprises 20 items (item score 0--6). The total score ranges from 0 to 120, with higher scores indicating higher levels of pain acceptance. Similar to the original questionnaire, the Spanish version yields a total score and two subscale scores for pain willingness and activity engagement. In addition, the CPAQ-SV demonstrates good criterion validity \[[@B34-ijerph-17-05556]\]. The total score alone was used in this study and showed appropriate internal consistency (α = 0.83).

### 2.3.7. Impairment and Functioning {#sec2dot3dot7-ijerph-17-05556}

Pain-related disability was assessed using the Impairment index of the Impairment and Functioning Inventory \[[@B36-ijerph-17-05556]\]. This 30-item instrument assesses the number of activities that patients have given up since pain began. The total score ranges from 0 to 30, with higher scores indicating higher pain-related disability. The impairment subscale shows good internal consistency (α = 0.98) and good criterion validity \[[@B36-ijerph-17-05556]\].

### 2.3.8. Healthcare Utilization {#sec2dot3dot8-ijerph-17-05556}

To assess healthcare utilization, respondents were asked questions on medical care sought for any spinal pain they had experienced since the previous interview. These questions specifically addressed the following aspects: (1) the number of general practitioner consultations; (2) the number of medical specialist consultations; (3) the number of physical therapist visits; and (4) the number of hospital emergency attendances. This study defined the outcome of interest as the total number of contacts with healthcare services. It has been found that data on healthcare utilization collected using self-reports and data collected from medical records are of comparable quality \[[@B37-ijerph-17-05556]\].

### 2.3.9. Medication Intake {#sec2dot3dot9-ijerph-17-05556}

Participants were also asked about the number of different medications they were taking. The variable "medication intake" was defined as the sum of the different categories of pain medications being taken at the time of assessment: weak opioids, strong opioids, non-steroid anti-inflammatory drugs, tricyclic antidepressants, muscle relaxants, sedatives, anticonvulsants, selective serotonin reuptake inhibitors, and over-the-counter analgesics.

2.4. Statistical Analysis {#sec2dot4-ijerph-17-05556}
-------------------------

Data analyses were performed using the Statistical Package for the Social Sciences version 22.0 (SPSS; Chicago, IL, USA). Firstly, categorical variables were expressed as frequencies, and continuous variables were expressed as means and standard deviations. Secondly, regression analyses were performed. Healthcare utilization and medication intake (number of medications consumed) are count response data. The Poisson regression model is the standard method used to model such data; however, its application is typically limited by the requirement of equality of means and variances. In the present study, the variances of the variables healthcare utilization and medication intake were greater than their means. This result was mainly due to the high frequency of zero data: that is, the data were over-dispersed. Thus, due to the skewed data distribution, negative binomial regression analyses were conducted. The regression coefficients provided are not directly interpretable because the negative binomial distribution was non-linear. Therefore, the coefficients were transformed into incident rate ratios (IRRs) by computing their exponentials (i.e., eβ). Firstly, all the proposed explanatory variables were screened for univariate associations with the dependent variables. Secondly, the explanatory variables that had a significant association with the dependent variables were included in the multivariate analysis. The probability of making a Type I error increases when conducting multiple analyses on the same outcome variable. Thus, the Bonferroni correction using a p value of 0.005 as a threshold to control Type I errors was applied. Negative binomial regression has been found to be robust with moderate sample sizes (\>50) \[[@B38-ijerph-17-05556]\].

3. Results {#sec3-ijerph-17-05556}
==========

[Table 1](#ijerph-17-05556-t001){ref-type="table"} shows the frequencies for categorical variables and means and standard deviations for continuous variables, and [Table 2](#ijerph-17-05556-t002){ref-type="table"} shows the comparison of women and men on the predictor and outcome variables.

Regarding healthcare utilization, at follow-up 1, univariate negative binomial regression analysis ([Table 3](#ijerph-17-05556-t003){ref-type="table"}) showed that higher pain acceptance was associated with less healthcare utilization (IRR = 0.984; CI: 0.973--0.995, *p* = 0.004): that is, each one-point increase in pain acceptance scores was associated with a 1.6% decrease in healthcare use. At follow-up 2 (i.e., 12 months after the baseline assessment), the only significant association was between pain-related disability and healthcare utilization (IRR = 1.071; CI: 1.033--1.111, *p* = 0.000): that is, each one-point increase in pain-related disability scores was associated with a 7.1% increase in healthcare use.

Regarding medication intake, at follow-up 1 (i.e., 6 months after the initial assessment), univariate negative binomial regression analysis ([Table 4](#ijerph-17-05556-t004){ref-type="table"}) showed a significant association between medication intake and male sex (IRR = 0.341; CI: 0.163--0.713, *p* = 0.004), pain intensity (IRR = 1.191, CI: 1.056--1.344, *p* = 0.004), pain anxiety (IRR = 1.016, CI: 1.007--1.024, *p* = 0.000), and pain acceptance (IRR = 0.979, CI: 0.969--0.990, *p* = 0.000). A multivariate contrast that introduced these four variables showed that only male sex (IRR = 0.311, CI: 0.149--0.649, *p* = 0.002) and pain acceptance (IRR = 0.978, CI: 0.968--0.989, *p* = 0.000) were significantly associated with medication intake. Male sex was associated with a 68.9% decrease in medication intake. In addition, each one-point increase in pain acceptance scores was associated with a 2.2% decrease in medication intake. At follow-up 2, univariate negative binomial regression analysis only showed a significant association between pain intensity and higher medication intake (IRR = 1.148, CI: 1.044--1.263, *p* = 0.004): that is, each one-point increase in pain intensity scores was associated with a 14.8% increase in medication intake.

4. Discussion {#sec4-ijerph-17-05556}
=============

The present study's objective was to prospectively assess the predictive value of pain acceptance and pain-related disability, pain intensity, depression, age, sex, work status, pain anxiety, and pain catastrophizing in relation to healthcare utilization and medication intake in people with non-specific spinal pain. Negative binomial regression analyses showed that pain acceptance significantly predicted healthcare utilization and medication intake when participants had experienced non-specific spinal pain for 12 to 15 months (follow-up 1). Six months later, pain-related disability and pain intensity predicted healthcare utilization and medication intake, respectively (follow-up 2). At follow-up 1, male sex significantly predicted lower medication intake. Contrary to the hypotheses, the rest of the variables did not significantly predict neither healthcare utilization nor medication intake.

The results of the present study showed that an acceptance response was associated with less healthcare utilization and medication intake. This finding is in line with the results of previous and prospective studies \[[@B20-ijerph-17-05556],[@B21-ijerph-17-05556],[@B22-ijerph-17-05556]\], which have shown that pain acceptance is predictive of healthcare utilization and medication intake. Comparisons with the results of these studies must take into account the following aspects: the present study had a follow-up period of 1 year and included two measurement occasions apart from that conducted at baseline. In contrast, the aforementioned studies had follow-up periods of 3.9 months, 3.7 months, and 4.6 months, respectively, and included just one measurement occasion. "Doctor shopping" and high medication intake characterize what has been called an acute pain response \[[@B39-ijerph-17-05556]\]. In contrast to an acceptance response, individuals with an acute pain response seek a total cure for their pain and put life goals on hold. Healthcare professionals should be ready to recognize this response in their patients. Several studies have shown that when total remission is the only goal contemplated by patients with chronic pain, there is a mismatch between the patients' and providers' objectives \[[@B40-ijerph-17-05556],[@B41-ijerph-17-05556]\] and patients will not be able to appreciate their progress. In this respect, a recent study in a sample of patients with spine pain showed that physiotherapeutic treatment was perceived as more effective among those with high acceptance than among those who reported low acceptance \[[@B42-ijerph-17-05556]\]. Goals set by the clinician and the patients are crucial to promoting adherence during the rehabilitation process \[[@B43-ijerph-17-05556],[@B44-ijerph-17-05556],[@B45-ijerph-17-05556]\]. This therapeutic strategy can be hindered by differences between the clinicians and patients concerning such goals. Healthcare professionals should encourage an acceptance response. If needed, they should refer patients to a psychologist specializing in cognitive behavioral therapy \[[@B46-ijerph-17-05556]\] or Acceptance and Commitment therapy, as these approaches have proven to be effective in reducing healthcare utilization and medication intake \[[@B47-ijerph-17-05556]\].

At follow-up 2, pain-related disability and pain intensity predicted healthcare utilization and medication intake, respectively. These results are consistent with a disability response. Patients with this response assume that pain is likely to be chronic. They see themselves as disabled, are highly sedentary, have abandoned their life goals, and are often depressed. There is increasing evidence that disability levels, rather than pain intensity, are the main reason patients with non-specific low back pain consult healthcare providers \[[@B12-ijerph-17-05556]\]. This shift in the predictive variables could be understood as a process-of-change model of pain self-management \[[@B48-ijerph-17-05556],[@B49-ijerph-17-05556],[@B50-ijerph-17-05556]\]. Based on this perspective and our results, it seems that during the first months of the chronic pain experience an acceptance response could prevent patients from using a pain management strategy that is exclusively centered on medical solutions. However, over time, their level of disability would be the determining factor in their approach to pain management. Thus, there is a need to (a) clearly identify the activities that the patients have abandoned since they began to experience spinal pain, and (b) encourage an acceptance response at an early stage of pain chronification given that pain acceptance entails engaging in normal life activities even if pain is present \[[@B20-ijerph-17-05556]\]. In this regard, international guidelines for the management of non-specific low back pain recommend an early return to normal activity and exercise \[[@B51-ijerph-17-05556]\].

At follow-up 2, pain intensity predicted medication intake. This result was similar to those of other prospective studies \[[@B52-ijerph-17-05556]\]. In addition, it has been suggested that (a) nociceptive processes are not only relevant in patients with acute pain, but also in patients with chronic pain, and that (b) the value of pain as a biological signal should not be underestimated \[[@B53-ijerph-17-05556]\]. Furthermore, the finding that sex was a predictor of medication use at the first measurement occasion could have been due to the application of different prescription patterns according to the patients' sex. Recent reviews have found gender-related biases in pain treatment that are due to the interaction of several factors. These factors include the characteristics of both the patients and the care providers \[[@B54-ijerph-17-05556],[@B55-ijerph-17-05556]\]. Specifically, female healthcare providers prescribed more antidepressants to female patients than to male patients, and sedatives were more frequently prescribed to men \[[@B54-ijerph-17-05556],[@B55-ijerph-17-05556]\].

The present study has some limitations. Firstly, many efforts have been made to reduce the possibility of Type I errors; however, Type II errors may be present in our analyses and significant associations may remain undetected. Secondly, there may have been differences in the unmeasured variables between dropouts and participants who completed the study, even though the dropout rate was low, and no significant differences were found between the participants who completed the three assessment sessions and those who did not. In order to prevent participant dropout or to reduce the dropout rate, future research should compensate the patients economically for taking part in the study. However, we were unable to do this due to restrictions imposed at our university on the use of financial incentives in clinical research. Thirdly, self-reporting was the only method used, and thus shared method variance may have influenced the results. Moreover, inaccurate recall could have biased the information provided by the participants on healthcare utilization. Nevertheless, several studies have shown good levels of reliability and high congruency rates between self-reporting and medical records for recall periods of up to 12 months \[[@B56-ijerph-17-05556]\]. Thus, future research replicating the present study should also include different assessment methods. Fourthly, only a small amount of the total variance in healthcare utilization and medication intake was explained by the variables included in the present study. Thus, in order to construct a predictive model, future research should consider other theoretically relevant variables. In this regard, a recent study has highlighted the relevance of health-seeking behavior: patients who were high health-seekers before the initial consultation for spine pain had a two and a half to three times greater risk of being high healthcare utilizers after consultation for spine pain \[[@B57-ijerph-17-05556]\]. Additionally, the present study did not adjust for any covariates, and this is a limitation that should be addressed in future research with larger samples. Fifthly, the duration of the present study was 1.5 years (counting from the baseline assessment to the 2nd follow-up). Future research should include longer follow-up periods to obtain a more complete picture of how healthcare utilization and medication intake evolves in patients with non-specific back pain. Finally, it should be acknowledged that the use of longitudinal data cannot establish causality at the same level of certainty as that obtained using experimental methods.

5. Conclusions {#sec5-ijerph-17-05556}
==============

In conclusion, besides pain intensity, psychological factors predict healthcare utilization and medication intake. Interestingly, the results of the present study suggest that the predictors changed over the course of time: at the beginning of the study, pain acceptance played a prominent role as a predictor, whereas 6 months later, disability---understood as the activities that patients have quit since they were in pain---became a predictor. Thus, during the early stages of spinal pain, an intervention program to encourage pain acceptance and prevent the abandonment of daily activities could contribute to reducing healthcare service costs and to improving the outcomes of rehabilitation interventions. The results of this study also indicated that medication prescriptions may be affected by sex bias. Future research should investigate how medical education could be improved, such that sex bias can be avoided when making prescriptions.
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ijerph-17-05556-t001_Table 1

###### 

Means and percentages of the predictive and outcome variables.

  Variable                               Mean (SD)       *N* (%)
  -------------------------------------- --------------- -----------
  Sex                                                    
  Female                                                 50 (79.4)
  Male                                                   13 (20.6)
  Employment status                                      
  Full-Time employed                                     29 (46)
  Homemaker                                              21 (33.3)
  Other (student, retired, unemployed)                   13 (20.7)
  Pain intensity                         4.79 (2.16)     
  Age                                    49.57 (16.49)   
  Depression                             11.54 (4.81)    
  Pain catastrophizing                   15.40 (12.50)   
  Pain anxiety                           57.29 (29.35)   
  Pain acceptance                        72.54 (22.26)   
  Disability                             2.71 (3.73)     
  Healthcare utilization follow-up 1     1.76 (1.78)     
  Healthcare utilization follow-up 2     0.85 (0.83)     
  Medication intake follow-up 1          0.95 (0.91)     
  Medication intake follow-up 2          1.20 (0.98)     

ijerph-17-05556-t002_Table 2

###### 

Comparison of women and men on the predictor and outcome variables. T-tests and chi-square.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------
  Variable                             Women                                     Men     t/χ^2^                                    *p*              
  ------------------------------------ ----------------------------------------- ------- ----------------------------------------- ------- -------- -------
  Employment status                    Full-Time employed: 21\                           Full-Time employed: 8\                            8.838    0.012
                                       Homemaker: 21\                                    Homemaker: 0\                                              
                                       Other (student, retired, unemployed): 8           Other (student, retired, unemployed): 5                    

  Pain intensity                       5.05                                      1.89    3.81                                      2.85    −1.487   0.158

  Age                                  50.66                                     16.58   45.38                                     16.09   −1.028   0.308

  Depression                           11.64                                     4.62    11.15                                     5.68    −0.322   0.748

  Pain Catastrophizing                 14.74                                     12.06   17.92                                     14.29   0.816    0.418

  Pain anxiety                         58.14                                     29.70   54.00                                     28.91   −0.450   0.654

  Pain acceptance                      72.34                                     20.34   73.31                                     29.50   0.139    0.890

  Disability                           2.78                                      3.55    2.46                                      4.50    −0.272   0.786

  Healthcare utilization follow-up 1   1.80                                      1.81    1.62                                      1.71    −0.332   0.741

  Healthcare utilization follow-up 2   0.84                                      0.81    0.88                                      0.89    −0.354   0.725

  Medication intake follow-up 1        1.10                                      0.91    0.38                                      0.65    −2.658   0.010

  Medication intake follow-up 2        1.35                                      0.97    0.81                                      0.91    −1.783   0.080
  ---------------------------------------------------------------------------------------------------------------------------------------------------------

ijerph-17-05556-t003_Table 3

###### 

Univariate negative binomial regression analysis of healthcare use.

  Predictors             Follow-Up 1   Follow-Up 2                                     
  ---------------------- ------------- -------------- --------- ------- -------------- ---------
  Sex (female/male)      0.949         0.498--1.807   0.874     1.045   0.596--1.832   0.877
  Employment status                                                                    
  Full-time employed     0.757         0.381--1.502   0.425     0.861   0.476--1.558   0.622
  Homemaker              0.673         0.323--1.401   0.290     0.805   0.424--1.529   0.507
  Other                  1             \-\-\--        \-\-\--   1       \-\-\--        \-\-\--
  Pain intensity         1.154         1.020--1.304   0.023     1.019   0.909--1.143   0.744
  Age                    1.001         0.985--1.017   0.935     0.989   0.975--1.004   0.164
  Depression             1.013         0.961--1.068   0.635     1.020   0.972--1.070   0.415
  Pain catastrophizing   1.010         0.989--1.031   0.362     1.009   0.991--1.028   0.339
  Pain anxiety           1.009         1.000--1.018   0.041     1.007   0.998--1.016   0.113
  Pain acceptance        0.984         0.973--0.995   0.004     0.993   0.983--1.004   0.200
  Disability             1.072         1.004--1.145   0.037     1.071   1.033--1.111   0.000

*Note.* IRR: Incidence Rate Ratio; CI: Confidence Interval. Bonferroni adjusted *p*-values.
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###### 

Univariate negative binomial regression analysis of medication intake.

  Predictors             Follow-Up 1   Follow-Up 2                                   
  ---------------------- ------------- -------------- ------- ------- -------------- -------
  Sex (female/male)      0.341         0.163--0.713   0.004   0.602   0.364--0.998   0.049
  Employment status                                                                  
  Full-time employed     1.144         0.554--2.362   0.717   0.909   0.541--1.529   0.719
  Homemaker              2.519         1.231--5.154   0.011   1.444   0.853--2.445   0.172
  Other                  1             \-\--          \-\--   1       \-\--          \-\--
  Pain intensity         1.191         1.056--1.344   0.004   1.148   1.044--1.263   0.004
  Age                    1.017         1.001--1.034   0.041   1.011   0.997--1.025   0.121
  Depression             1.061         1.014--1.111   0.011   1.053   1.013--1.094   0.008
  Pain catastrophizing   1.024         1.005--1.043   0.014   1.006   0.990--1.022   0.440
  Pain anxiety           1.016         1.007--1.024   0.000   1.008   1.001--1.016   0.031
  Pain acceptance        0.979         0.969--0.990   0.000   0.988   0.980--0.997   0.011
  Disability             1.036         0.972--1.104   0.277   1.014   0.957--1.075   0.637

Note. IRR: Incidence Rate Ratio; CI: Confidence Interval. Bonferroni adjusted *p*-values.
